NEURO-SYS
Noelle Callizot is a highly experienced professional in the field of neuropharmacology and biotechnology, currently serving as Co-founder and Chief Scientific Officer at NEURO-SYS since January 2013 and as CSO at Alzprotect SAS since January 2018. With a robust background in pharmaceutical development for neurodegenerative diseases, Noelle has held various leadership positions, including Head of Research at Neuronexpert and Director of Neuropharmacology at Phytopharm LLC. Noelle's extensive expertise encompasses preclinical pharmacological studies, drug discovery, and the management of research and development programs. Educational qualifications include a PharmD, a PhD in Pharmacology, and an Accreditation to Direct Research from the University of Strasbourg.
This person is not in any teams
This person is not in any offices
NEURO-SYS
Neuro-Sys is a research-intensive and innovative organisation specialising in pharmacology and in advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development in the CNS and PNS fields. We provide pharmacological profiles of lead compounds and explore their underlying mechanism of action and studies to determine the neuroprotective activity. We’re dedicated to providing high-level technical expertise in a collaborative relationship with our clients and accompany you along the drug development stages, from preclinical to clinical. Our expertise: › Alzheimer’s disease (AD) › Parkinson’s disease (PD) › Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease) › Multiple Sclerosis (MS) › Peripheral Neuropathies › Blood Brain Barrier DRUG DEVELOPMENT SERVICES Our experts in drug and pharmaceutical development provide expert guidance on: •The design of your drug discovery development plan (pre-clinical testing in vitro and in vivo models) •The design of your preclinical research programs (in vitro/ in vivo, mode of action) •The preclinical (Pharmacology, PK and ADME) development and early clinical designs (PoC studies) •The writing of research projects, investigator brochures (IB), IMPD, ODD submission (FDA/EMA) in neuro indication